An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF)

被引:10
作者
Brown, Russell W. [1 ]
Kirby, Seth L. [2 ]
Denton, Adam R. [2 ]
Dose, John M. [3 ]
Cummins, Elizabeth D. [2 ]
Gill, Wesley Drew [1 ]
Burgess, Katherine C. [1 ]
机构
[1] East Tennessee State Univ, James H Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA
[2] East Tennessee State Univ, Dept Psychol, Johnson City, TN 37614 USA
[3] St Norbert Coll, Dept Psychol, De Pere, WI 54115 USA
关键词
Dopamine D2 receptor; Schizophrenia; Adolescence; Nicotine; Antipsychotics; Conditioned place preference; CONDITIONED PLACE PREFERENCE; CUE-INDUCED REINSTATEMENT; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ANTIPSYCHOTIC-DRUGS; DOPAMINE ANTAGONISTS; PARKINSONS-DISEASE; LOCOMOTOR-ACTIVITY; SEEKING BEHAVIOR; RATS;
D O I
10.1016/j.schres.2017.03.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This study analyzed the associative properties of nicotine in a conditioned place preference (CPP) paradigm in adolescent rats neonatally treated with quinpirole (NQ) or saline (NS). NQ produces dopamine D2 receptor super-sensitivity that persists throughout the animal's lifetime, and therefore has relevance towards schizophrenia. In two experiments, rats were ip administered quinpirole (1 mg/kg) or saline from postnatal day (P) 1-21. After an initial preference test at P42-43, animals were conditioned for eight consecutive days with saline or nicotine (0.6 mg/kg free base) in Experiment 1 or saline or nicotine (1.8 mg/kg free base) in Experiment 2. In addition, there were NQ and NS groups in each experiment given the antipsychotic haloperidol (0.05mg/kg) or clozapine (2.5 mg/kg) before nicotine conditioning. A drug free post-conditioning testwas administered at P52. At P53, the nucleus accumbens (NAc) was analyzed for glial cell-line derived neurotrophic factor (GDNF). Results revealed that NQ enhanced nicotine CPP, but blunted the aversive properties of nicotine. Haloperidol was more effective than clozapine at blocking nicotine CPP in Experiment 1, but neither antipsychotic affected nicotine conditioned place aversion in Experiment 2. NQ increased accumbal GDNF which was sensitized in NQ rats conditioned to nicotine in Experiment 1, but the aversive dose of nicotine reduced GDNF in NQ animals in Experiment 2. Both antipsychotics in combination with the aversive dose of nicotine decreased accumbal GDNF. In sum, increased D2 receptor sensitivity influenced the associative properties and GDNF response to nicotine which has implications towards pharmacological targets for smoking cessation in schizophrenia. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [41] Role of Glial Cell Line-Derived Neurotrophic Factor in the Maintenance of Adult Mesencephalic Catecholaminergic Neurons
    Enterria-Morales, Daniel
    Lopez-Lopez, Ivette
    Lopez-Barneo, Jose
    d'Anglemont de Tassigny, Xavier
    [J]. MOVEMENT DISORDERS, 2020, 35 (04) : 565 - 576
  • [42] Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain
    Hadaczek, Piotr
    Johnston, Louisa
    Forsayeth, John
    Bankiewicz, Krystof S.
    [J]. NEUROPHARMACOLOGY, 2010, 58 (07) : 1114 - 1121
  • [43] Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons
    Åkerud, P
    Alberch, J
    Eketjäll, S
    Wagner, J
    Arenas, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) : 70 - 78
  • [44] Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease
    Zheng, JS
    Tang, LL
    Zheng, SS
    Zhan, RY
    Zhou, YQ
    Goudreau, J
    Kaufman, D
    Chen, AF
    [J]. MOLECULAR BRAIN RESEARCH, 2005, 134 (01): : 155 - 161
  • [45] Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity
    Xing, Bin
    Xin, Tao
    Zhao, Lingling
    Hunter, Randy L.
    Chen, Yan
    Bing, Guoying
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2010, 225 (1-2) : 43 - 51
  • [46] Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons
    Enterria-Morales, Daniel
    Lopez-Gonzalez del Rey, Natalia
    Blesa, Javier
    Lopez-Lopez, Ivette
    Gallet, Sarah
    Prevot, Vincent
    Lopez-Barneo, Jose
    d'Anglemont de Tassigny, Xavier
    [J]. BRAIN COMMUNICATIONS, 2020, 2 (02)
  • [47] Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration
    Sidorova, Yulia A.
    Saarma, Mart
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 20
  • [48] Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease
    Whone, Alan
    Luz, Matthias
    Boca, Mihaela
    Woolley, Max
    Mooney, Lucy
    Dharia, Sonali
    Broadfoot, Jack
    Cronin, David
    Schroers, Christian
    Barua, Neil U.
    Longpre, Lara
    Barclay, C. Lynn
    Boiko, Chris
    Johnson, Greg A.
    Fibiger, H. Christian
    Harrison, Rob
    Lewis, Owen
    Pritchard, Gemma
    Howell, Mike
    Irving, Charlie
    Johnson, David
    Kinch, Suk
    Marshall, Christopher
    Lawrence, Andrew D.
    Blinder, Stephan
    Sossi, Vesna
    Stoessl, A. Jon
    Skinner, Paul
    Mohr, Erich
    Gill, Steven S.
    [J]. BRAIN, 2019, 142 : 512 - 525
  • [49] Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor
    Chun, HS
    Yoo, MS
    DeGiorgio, LA
    Volpe, BT
    Peng, D
    Baker, H
    Peng, C
    Son, JH
    [J]. EXPERIMENTAL NEUROLOGY, 2002, 173 (02) : 235 - 244
  • [50] GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR GENE THERAPY AMELIORATES CHRONIC HYPERPROLACTINEMIA IN SENILE RATS
    Morel, G. R.
    Sosa, Y. E.
    Bellini, M. J.
    Carri, N. G.
    Rodriguez, S. S.
    Bohn, M. C.
    Goya, R. G.
    [J]. NEUROSCIENCE, 2010, 167 (03) : 946 - 953